PRICE T ROWE ASSOCIATES INC /MD/ - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$462,435
-19.9%
2,734,838
+2.8%
0.07%
-15.0%
Q2 2023$577,146
+28.0%
2,661,492
+7.3%
0.08%
+19.4%
Q1 2023$450,751
-2.9%
2,481,560
+5.0%
0.07%
-10.7%
Q4 2022$464,389
-99.9%
2,363,304
+6.6%
0.08%
-8.5%
Q3 2022$498,479,000
+94.6%
2,216,146
+9.4%
0.08%
+156.2%
Q2 2022$256,162,000
-4.3%
2,024,839
-4.1%
0.03%
+18.5%
Q1 2022$267,683,000
+4.5%
2,111,234
+8.0%
0.03%
+17.4%
Q4 2021$256,153,000
+13.8%
1,955,366
+6.2%
0.02%
+9.5%
Q3 2021$225,164,000
+10.8%
1,840,631
+3.2%
0.02%
+10.5%
Q2 2021$203,275,000
-0.0%
1,783,268
+5.5%
0.02%
-5.0%
Q1 2021$203,282,000
+40.5%
1,690,775
+18.7%
0.02%
+33.3%
Q4 2020$144,681,000
+36.1%
1,424,161
+3.6%
0.02%
+25.0%
Q3 2020$106,322,000
-30.2%
1,375,088
+0.6%
0.01%
-36.8%
Q2 2020$152,322,000
+16.2%
1,366,610
-24.9%
0.02%
-9.5%
Q1 2020$131,036,000
+137.7%
1,819,943
+148.8%
0.02%
+200.0%
Q4 2019$55,119,000
+637.5%
731,607
+59.7%
0.01%
+600.0%
Q3 2019$7,474,000
-17.7%
457,981
+1.0%
0.00%0.0%
Q2 2019$9,077,000453,3740.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders